<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Cathylewwho</id>
	<title>WikEM - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Cathylewwho"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/wiki/Special:Contributions/Cathylewwho"/>
	<updated>2026-05-14T01:14:38Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22806</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22806"/>
		<updated>2014-08-12T16:00:58Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
*Diagnosed in 2% of febrile travelers and caused by ''[[Salmonella]] enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
*Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
*Prior vaccination does not exclude infection&lt;br /&gt;
*Incubation period 1-3 weeks with chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
*Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms==&lt;br /&gt;
===Classic symptoms===&lt;br /&gt;
*[[Bradycardia]] relative to fever&lt;br /&gt;
&lt;br /&gt;
===Initial symptoms===&lt;br /&gt;
*[[Fever]]&lt;br /&gt;
*[[Abdominal Pain]]&lt;br /&gt;
*[[Headache]]&lt;br /&gt;
&lt;br /&gt;
===Subsequent symptoms===&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
*Cough&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
*GI bleeding&lt;br /&gt;
*Transaminitis&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up==&lt;br /&gt;
*Blood culture&lt;br /&gt;
*Urine culture&lt;br /&gt;
*Stool culture&lt;br /&gt;
*“Rose spot” aspiration&lt;br /&gt;
*Bone marrow culture (most sensitive)&lt;br /&gt;
*Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
*Small-bowel ulceration&lt;br /&gt;
*Intestinal perforation&lt;br /&gt;
*[[Anemia]]&lt;br /&gt;
*[[DIC]]&lt;br /&gt;
*[[Pneumonia]]&lt;br /&gt;
*[[Meningitis]]&lt;br /&gt;
*[[Myocarditis]]&lt;br /&gt;
*[[Cholecystitis]]&lt;br /&gt;
*[[Renal Failure]]&lt;br /&gt;
*Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
*[[Malaria]]&lt;br /&gt;
*[[Typhus]]&lt;br /&gt;
*Viral hepatitis&lt;br /&gt;
*Amebic Liver Abscess&lt;br /&gt;
*Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
*Consultation with Infectious Disease should be considered since there are increasingly multidrug resistant strains of S. Typhi and coinfection with diseases such as [[Malaria]] may complicate treatment.  The therapy favors the use of fluorquinolones unless suspected or known resistance.&amp;lt;ref&amp;gt;Bhutta ZA. et al. Current concepts in the diagnosis and treatment of typhoid fever. BMJ. 2006 Jul 8;333(7558):78-82. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489205/pdf/bmj33300078.pdf PDF]&amp;lt;/ref&amp;gt;&lt;br /&gt;
===Antibiotics===&lt;br /&gt;
{{Typhoid Antibiotics}}&lt;br /&gt;
&lt;br /&gt;
===Adjunctive Therapy===&lt;br /&gt;
*If associated delirium, coma, shock, and/or [[DIC]]: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
*Tintinalli et. al. Typhoid Fever. In: Tintinalli et. al. Emergency Medicine A Comprehensive Study Guide. New York, NY: McGraw Hill. 2011. 1082-1084. &lt;br /&gt;
*Hohmann, E. Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever . In: UpToDate. Last updated: July 2013. Accessed July 30, 2014.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22800</id>
		<title>Hydrogen sulfide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22800"/>
		<updated>2014-08-12T14:52:25Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hydrogen Sulfide Poisoning. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==General Information:==&lt;br /&gt;
&lt;br /&gt;
Colorless, flammable gas&lt;br /&gt;
&lt;br /&gt;
Encountered in following industries: oil, gas, organic decomposition (sewer and manure), roofing asphalt tanks&lt;br /&gt;
&lt;br /&gt;
Most common fatal gas exposure&lt;br /&gt;
&lt;br /&gt;
“Rotten egg” smell which diminishes with high concentrations or prolonged low concentration exposure&lt;br /&gt;
&lt;br /&gt;
Often used in suicide attempts: acidic detergent (toilet bowl cleaner) is mixed with bath salts or pesticides&lt;br /&gt;
&lt;br /&gt;
==Mechanisms of toxicity:==&lt;br /&gt;
&lt;br /&gt;
*Highly lipid soluble&lt;br /&gt;
&lt;br /&gt;
*Disrupts oxidative phosphorylation by inhibiting cytochrome oxidase aa3 (toxicity through cellular asphyxia and impairs ATP production) =&amp;gt; lactate accumulation and metabolic acidosis&lt;br /&gt;
&lt;br /&gt;
*Causes hyperpolarization of potassium-mediated channels in neurons&lt;br /&gt;
&lt;br /&gt;
*Potentiates neuronal inhibitory mechanisms&lt;br /&gt;
&lt;br /&gt;
*Alters brain neurotransmitter content and release&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
*Respiratory: dyspnea, cyanosis, hemoptysis, rales, delayed pulmonary edema&lt;br /&gt;
&lt;br /&gt;
*Ophthalmic: conjunctivitis, corneal ulceration, corneal scarring&lt;br /&gt;
&lt;br /&gt;
*Central nervous system: headache, weakness, disequilibrium, intention tremor, muscle rigidity, loss of consciousness, seizures, coma&lt;br /&gt;
&lt;br /&gt;
*Gastrointestinal: green-gray line on gingiva, nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular: chest pain, bradycardia&lt;br /&gt;
&lt;br /&gt;
*Neuropsychiatric: amnesia, lack of insight, disorientation, delirium, dementia&lt;br /&gt;
*Death&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Carbon Monoxide Toxicity&lt;br /&gt;
&lt;br /&gt;
Cyanide Toxicity&lt;br /&gt;
&lt;br /&gt;
Hydrocarbon Toxicity&lt;br /&gt;
&lt;br /&gt;
Smoke Inhalation Injury&lt;br /&gt;
&lt;br /&gt;
==Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
*No single test to verify exposure or levels&lt;br /&gt;
&lt;br /&gt;
*ABG: metabolic acidosis and normal oxygen saturation (unless pulmonary edema present)&lt;br /&gt;
&lt;br /&gt;
*Elevated lactate&lt;br /&gt;
&lt;br /&gt;
*Discolored copper coins found on patient may be helpful in diagnosis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
*Removal from source&lt;br /&gt;
&lt;br /&gt;
*100% oxygen&lt;br /&gt;
&lt;br /&gt;
*Can give nitrite component of cyanide antidote kit (do NOT give the thiosulfate portion): &lt;br /&gt;
**Theoretically increasing methemoglobin formation in blood will cause conversion of sulfide to sulfmethemoglonin (less toxic)&lt;br /&gt;
**Sodium nitrite (3% NaNO2) IV over 2-4 minutes&lt;br /&gt;
**Adult dose: 10 mL&lt;br /&gt;
**Obtain methemoglobin level 30 minutes after dose (desired level &amp;lt; 30%)&lt;br /&gt;
&lt;br /&gt;
*Hyperbaric oxygen therapy (though not proven to have any benefit)&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
*Admission, likely to MICU&lt;br /&gt;
&lt;br /&gt;
*Toxicology consult&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli et. al. Hydrogen Sulfide. In: Tintinalli et. al. Emergency Medicine A Comprehensive Study Guide. New York, NY: McGraw Hill. 2011. 1320.&lt;br /&gt;
&lt;br /&gt;
Goldfrank et. al. Hydrogen Sulfide Poisoning. In: Goldfrank et. al. Goldfrank’s Toxicologic Emergencies. New York, NY: McGraw Hill. 2002. 1504-1507. &lt;br /&gt;
&lt;br /&gt;
Gresham, C. Hydrogen Sulfide Poisoning. Medscape: http://emedicine.medscape.com/article/815139-overview. Updated Jan 27, 2014. Accessed Aug 8, 2014.&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22799</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22799"/>
		<updated>2014-08-12T14:51:08Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
*Consultation with Infectious Disease should be considered since there are increasingly multidrug resistant strains of S. Typhi and coinfection with diseases such as [[Malaria]] may complicate treatment.  The therapy favors the use of fluorquinolones unless suspected or known resistance.&amp;lt;ref&amp;gt;Bhutta ZA. et al. Current concepts in the diagnosis and treatment of typhoid fever. BMJ. 2006 Jul 8;333(7558):78-82. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489205/pdf/bmj33300078.pdf PDF]&amp;lt;/ref&amp;gt;&lt;br /&gt;
===Antibiotics===&lt;br /&gt;
'''Oral therapy with Quinolone Susceptibility:'''&lt;br /&gt;
*Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
'''Parenteral Therapy with Quinolone Susceptibility: '''&lt;br /&gt;
*Ciprofloxacin 400 mg IV q 12 hrs x 10 days&lt;br /&gt;
&lt;br /&gt;
'''Parenteral Therapy with Quinolone Resistance:'''&lt;br /&gt;
&lt;br /&gt;
''if nalidixic acid resistant, can assume fluoroquinolone resistant''&lt;br /&gt;
*Ceftriaxone 2mg IV q 24 hrs x 14 days &lt;br /&gt;
::'''OR'''&lt;br /&gt;
*Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
'''Oral Therapy with Quinolone Resistance:'''&lt;br /&gt;
*Azithromycin 1 g PO daily x 5 days  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Adjunctive Therapy===&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Tintinalli et. al. Typhoid Fever. In: Tintinalli et. al. Emergency Medicine A Comprehensive Study Guide. New York, NY: McGraw Hill. 2011. 1082-1084. &lt;br /&gt;
&lt;br /&gt;
Hohmann, E. Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever . In: UpToDate. Last updated: July 2013. Accessed July 30, 2014.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22798</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22798"/>
		<updated>2014-08-11T20:58:18Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
*Consultation with Infectious Disease should be considered since there are increasingly multidrug resistant strains of S. Typhi and coinfection with diseases such as [[Malaria]] may complicate treatment.  The therapy favors the use of fluorquinolones unless suspected or known resistance.&amp;lt;ref&amp;gt;Bhutta ZA. et al. Current concepts in the diagnosis and treatment of typhoid fever. BMJ. 2006 Jul 8;333(7558):78-82. [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489205/pdf/bmj33300078.pdf PDF]&amp;lt;/ref&amp;gt;&lt;br /&gt;
===Antibiotics===&lt;br /&gt;
'''Oral therapy with Quinolone Susceptibility:'''&lt;br /&gt;
*Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
'''Parenteral Therapy with Quinolone Susceptibility: '''&lt;br /&gt;
*Ciprofloxacin 400 mg IV q 12 hrs x 10 days&lt;br /&gt;
&lt;br /&gt;
'''Parenteral Therapy with Quinolone Resistance:'''&lt;br /&gt;
&lt;br /&gt;
''if nalidixic acid resistant, can assume fluoroquinolone resistant''&lt;br /&gt;
*Ceftriaxone 2mg IV q 24 hrs x 14 days &lt;br /&gt;
::'''OR'''&lt;br /&gt;
*Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
'''Oral Therapy with Quinolone Resistance:'''&lt;br /&gt;
*Azithromycin 1 g PO daily x 5 days  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Adjunctive Therapy===&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Tintinalli et. al. Typhoid Fever. In: Tintinalli et. al. Emergency Medicine A Comprehensive Study Guide. New York, NY: McGraw Hill. 2010. &lt;br /&gt;
&lt;br /&gt;
Hohmann, E. Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever . In: UpToDate. Last updated: July 2013. Accessed July 30, 2014.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22797</id>
		<title>Hydrogen sulfide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22797"/>
		<updated>2014-08-11T20:52:40Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hydrogen Sulfide Poisoning. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==General Information:==&lt;br /&gt;
&lt;br /&gt;
Colorless, flammable gas&lt;br /&gt;
&lt;br /&gt;
Encountered in following industries: oil, gas, organic decomposition (sewer and manure), roofing asphalt tanks&lt;br /&gt;
&lt;br /&gt;
Most common fatal gas exposure&lt;br /&gt;
&lt;br /&gt;
“Rotten egg” smell which diminishes with high concentrations or prolonged low concentration exposure&lt;br /&gt;
&lt;br /&gt;
Often used in suicide attempts: acidic detergent (toilet bowl cleaner) is mixed with bath salts or pesticides&lt;br /&gt;
&lt;br /&gt;
==Mechanisms of toxicity:==&lt;br /&gt;
&lt;br /&gt;
*Highly lipid soluble&lt;br /&gt;
&lt;br /&gt;
*Disrupts oxidative phosphorylation by inhibiting cytochrome oxidase aa3 (toxicity through cellular asphyxia and impairs ATP production) =&amp;gt; lactate accumulation and metabolic acidosis&lt;br /&gt;
&lt;br /&gt;
*Causes hyperpolarization of potassium-mediated channels in neurons&lt;br /&gt;
&lt;br /&gt;
*Potentiates neuronal inhibitory mechanisms&lt;br /&gt;
&lt;br /&gt;
*Alters brain neurotransmitter content and release&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
*Respiratory: dyspnea, cyanosis, hemoptysis, rales, delayed pulmonary edema&lt;br /&gt;
&lt;br /&gt;
*Ophthalmic: conjunctivitis, corneal ulceration, corneal scarring&lt;br /&gt;
&lt;br /&gt;
*Central nervous system: headache, weakness, disequilibrium, intention tremor, muscle rigidity, loss of consciousness, seizures, coma&lt;br /&gt;
&lt;br /&gt;
*Gastrointestinal: green-gray line on gingiva, nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular: chest pain, bradycardia&lt;br /&gt;
&lt;br /&gt;
*Neuropsychiatric: amnesia, lack of insight, disorientation, delirium, dementia&lt;br /&gt;
*Death&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Carbon Monoxide Toxicity&lt;br /&gt;
&lt;br /&gt;
Cyanide Toxicity&lt;br /&gt;
&lt;br /&gt;
Hydrocarbon Toxicity&lt;br /&gt;
&lt;br /&gt;
Smoke Inhalation Injury&lt;br /&gt;
&lt;br /&gt;
==Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
*No single test to verify exposure or levels&lt;br /&gt;
&lt;br /&gt;
*ABG: metabolic acidosis and normal oxygen saturation (unless pulmonary edema present)&lt;br /&gt;
&lt;br /&gt;
*Elevated lactate&lt;br /&gt;
&lt;br /&gt;
*Discolored copper coins found on patient may be helpful in diagnosis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
*Removal from source&lt;br /&gt;
&lt;br /&gt;
*100% oxygen&lt;br /&gt;
&lt;br /&gt;
*Can give nitrite component of cyanide antidote kit (do NOT give the thiosulfate portion): &lt;br /&gt;
**Theoretically increasing methemoglobin formation in blood will cause conversion of sulfide to sulfmethemoglonin (less toxic)&lt;br /&gt;
**Sodium nitrite (3% NaNO2) IV over 2-4 minutes&lt;br /&gt;
**Adult dose: 10 mL&lt;br /&gt;
**Obtain methemoglobin level 30 minutes after dose (desired level &amp;lt; 30%)&lt;br /&gt;
&lt;br /&gt;
*Hyperbaric oxygen therapy (though not proven to have any benefit)&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
*Admission, likely to MICU&lt;br /&gt;
&lt;br /&gt;
*Toxicology consult&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli et. al. Hydrogen Sulfide. In: Tintinalli et. al. Emergency Medicine A Comprehensive Study Guide. New York, NY: McGraw Hill. 2010. &lt;br /&gt;
&lt;br /&gt;
Goldfrank et. al. Hydrogen Sulfide Poisoning. In: Goldfrank et. al. Goldfrank’s Toxicologic Emergencies. New York, NY: McGraw Hill. 2002. 1504-1507. &lt;br /&gt;
&lt;br /&gt;
Gresham, C. Hydrogen Sulfide Poisoning. Medscape: http://emedicine.medscape.com/article/815139-overview. Updated Jan 27, 2014. Accessed Aug 8, 2014.&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22796</id>
		<title>Hydrogen sulfide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22796"/>
		<updated>2014-08-11T13:32:59Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hydrogen Sulfide Poisoning. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==General Information:==&lt;br /&gt;
&lt;br /&gt;
Colorless, flammable gas&lt;br /&gt;
&lt;br /&gt;
Encountered in following industries: oil, gas, organic decomposition (sewer and manure), roofing asphalt tanks&lt;br /&gt;
&lt;br /&gt;
Most common fatal gas exposure&lt;br /&gt;
&lt;br /&gt;
“Rotten egg” smell which diminishes with high concentrations or prolonged low concentration exposure&lt;br /&gt;
&lt;br /&gt;
Often used in suicide attempts: acidic detergent (toilet bowl cleaner) is mixed with bath salts or pesticides&lt;br /&gt;
&lt;br /&gt;
==Mechanisms of toxicity:==&lt;br /&gt;
&lt;br /&gt;
*Highly lipid soluble&lt;br /&gt;
&lt;br /&gt;
*Disrupts oxidative phosphorylation by inhibiting cytochrome oxidase aa3 (toxicity through cellular asphyxia and impairs ATP production) =&amp;gt; lactate accumulation and metabolic acidosis&lt;br /&gt;
&lt;br /&gt;
*Causes hyperpolarization of potassium-mediated channels in neurons&lt;br /&gt;
&lt;br /&gt;
*Potentiates neuronal inhibitory mechanisms&lt;br /&gt;
&lt;br /&gt;
*Alters brain neurotransmitter content and release&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
*Respiratory: dyspnea, cyanosis, hemoptysis, rales, delayed pulmonary edema&lt;br /&gt;
&lt;br /&gt;
*Ophthalmic: conjunctivitis, corneal ulceration, corneal scarring&lt;br /&gt;
&lt;br /&gt;
*Central nervous system: headache, weakness, disequilibrium, intention tremor, muscle rigidity, loss of consciousness, seizures, coma&lt;br /&gt;
&lt;br /&gt;
*Gastrointestinal: green-gray line on gingiva, nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular: chest pain, bradycardia&lt;br /&gt;
&lt;br /&gt;
*Neuropsychiatric: amnesia, lack of insight, disorientation, delirium, dementia&lt;br /&gt;
*Death&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Carbon Monoxide Toxicity&lt;br /&gt;
&lt;br /&gt;
Cyanide Toxicity&lt;br /&gt;
&lt;br /&gt;
Hydrocarbon Toxicity&lt;br /&gt;
&lt;br /&gt;
Smoke Inhalation Injury&lt;br /&gt;
&lt;br /&gt;
==Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
*No single test to verify exposure or levels&lt;br /&gt;
&lt;br /&gt;
*ABG: metabolic acidosis and normal oxygen saturation (unless pulmonary edema present)&lt;br /&gt;
&lt;br /&gt;
*Elevated lactate&lt;br /&gt;
&lt;br /&gt;
*Discolored copper coins found on patient may be helpful in diagnosis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
*Removal from source&lt;br /&gt;
&lt;br /&gt;
*100% oxygen&lt;br /&gt;
&lt;br /&gt;
*Can give nitrite component of cyanide antidote kit (do NOT give the thiosulfate portion): &lt;br /&gt;
**Theoretically increasing methemoglobin formation in blood will cause conversion of sulfide to sulfmethemoglonin (less toxic)&lt;br /&gt;
**Sodium nitrite (3% NaNO2) IV over 2-4 minutes&lt;br /&gt;
**Adult dose: 10 mL&lt;br /&gt;
**Obtain methemoglobin level 30 minutes after dose (desired level &amp;lt; 30%)&lt;br /&gt;
&lt;br /&gt;
*Hyperbaric oxygen therapy (though not proven to have any benefit)&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
*Admission, likely to MICU&lt;br /&gt;
&lt;br /&gt;
*Toxicology consult&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli’s Emergency Medicine&lt;br /&gt;
&lt;br /&gt;
Goldfrank’s Toxicologic Emergencies&lt;br /&gt;
&lt;br /&gt;
Medscape&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22795</id>
		<title>Hydrogen sulfide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22795"/>
		<updated>2014-08-11T13:32:40Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hydrogen Sulfide Poisoning. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==General Information:==&lt;br /&gt;
&lt;br /&gt;
Colorless, flammable gas&lt;br /&gt;
&lt;br /&gt;
Encountered in following industries: oil, gas, organic decomposition (sewer and manure), roofing asphalt tanks&lt;br /&gt;
&lt;br /&gt;
Most common fatal gas exposure&lt;br /&gt;
&lt;br /&gt;
“Rotten egg” smell which diminishes with high concentrations or prolonged low concentration exposure&lt;br /&gt;
&lt;br /&gt;
Often used in suicide attempts: acidic detergent (toilet bowl cleaner) is mixed with bath salts or pesticides&lt;br /&gt;
&lt;br /&gt;
==Mechanisms of toxicity:==&lt;br /&gt;
&lt;br /&gt;
*Highly lipid soluble&lt;br /&gt;
&lt;br /&gt;
*Disrupts oxidative phosphorylation by inhibiting cytochrome oxidase aa3 (toxicity through cellular asphyxia and impairs ATP production) =&amp;gt; lactate accumulation and metabolic acidosis&lt;br /&gt;
&lt;br /&gt;
*Causes hyperpolarization of potassium-mediated channels in neurons&lt;br /&gt;
&lt;br /&gt;
*Potentiates neuronal inhibitory mechanisms&lt;br /&gt;
&lt;br /&gt;
*Alters brain neurotransmitter content and release&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
*Respiratory: dyspnea, cyanosis, hemoptysis, rales, delayed pulmonary edema&lt;br /&gt;
&lt;br /&gt;
*Ophthalmic: conjunctivitis, corneal ulceration, corneal scarring&lt;br /&gt;
&lt;br /&gt;
*Central nervous system: headache, weakness, disequilibrium, intention tremor, muscle rigidity, loss of consciousness, seizures, coma&lt;br /&gt;
&lt;br /&gt;
*Gastrointestinal: green-gray line on gingiva, nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular: chest pain, bradycardia&lt;br /&gt;
&lt;br /&gt;
*Neuropsychiatric: amnesia, lack of insight, disorientation, delirium, dementia&lt;br /&gt;
*Death&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Carbon Monoxide Toxicity&lt;br /&gt;
&lt;br /&gt;
Cyanide Toxicity&lt;br /&gt;
&lt;br /&gt;
Hydrocarbon Toxicity&lt;br /&gt;
&lt;br /&gt;
Smoke Inhalation Injury&lt;br /&gt;
&lt;br /&gt;
==Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
*No single test to verify exposure or levels&lt;br /&gt;
&lt;br /&gt;
*ABG: metabolic acidosis and normal oxygen saturation (unless pulmonary edema present)&lt;br /&gt;
&lt;br /&gt;
*Elevated lactate&lt;br /&gt;
&lt;br /&gt;
*Discolored copper coins found on patient may be helpful in diagnosis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
*Removal from source&lt;br /&gt;
&lt;br /&gt;
*100% oxygen&lt;br /&gt;
&lt;br /&gt;
*Can give nitrite component of cyanide antidote kit (do NOT give the thiosulfate portion): &lt;br /&gt;
**Theoretically increasing methemoglobin formation in blood will cause conversion of sulfide to sulfmethemoglonin (less toxic)&lt;br /&gt;
**Sodium nitrite (3% NaNO2) IV over 2-4 minutes&lt;br /&gt;
**Adult dose: 10 mL&lt;br /&gt;
**Obtain methemoglobin level 30 minutes after dose (desired level &amp;lt; 30%)&lt;br /&gt;
&lt;br /&gt;
*Hyperbaric oxygen therapy (though not proven to have any benefit)&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
*Admission, likely to MICU&lt;br /&gt;
&lt;br /&gt;
*Toxicology consult&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli’s Emergency Medicine&lt;br /&gt;
&lt;br /&gt;
Goldfrank’s Toxicologic Emergencies&lt;br /&gt;
&lt;br /&gt;
Medscape&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
#Decontamination of skin/eyes&lt;br /&gt;
#O2 100% NRB&lt;br /&gt;
#Consider giving nitrite component of CN kit (do not give thiosulfate portion)&lt;br /&gt;
##Low level MetHb may enhance conversion of sulfide to less toxic sulfmethemoglobin&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22794</id>
		<title>Hydrogen sulfide toxicity</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Hydrogen_sulfide_toxicity&amp;diff=22794"/>
		<updated>2014-08-11T13:32:19Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: /* Background */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hydrogen Sulfide Poisoning. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==General Information:==&lt;br /&gt;
&lt;br /&gt;
Colorless, flammable gas&lt;br /&gt;
&lt;br /&gt;
Encountered in following industries: oil, gas, organic decomposition (sewer and manure), roofing asphalt tanks&lt;br /&gt;
&lt;br /&gt;
Most common fatal gas exposure&lt;br /&gt;
&lt;br /&gt;
“Rotten egg” smell which diminishes with high concentrations or prolonged low concentration exposure&lt;br /&gt;
&lt;br /&gt;
Often used in suicide attempts: acidic detergent (toilet bowl cleaner) is mixed with bath salts or pesticides&lt;br /&gt;
&lt;br /&gt;
==Mechanisms of toxicity:==&lt;br /&gt;
&lt;br /&gt;
*Highly lipid soluble&lt;br /&gt;
&lt;br /&gt;
*Disrupts oxidative phosphorylation by inhibiting cytochrome oxidase aa3 (toxicity through cellular asphyxia and impairs ATP production) =&amp;gt; lactate accumulation and metabolic acidosis&lt;br /&gt;
&lt;br /&gt;
*Causes hyperpolarization of potassium-mediated channels in neurons&lt;br /&gt;
&lt;br /&gt;
*Potentiates neuronal inhibitory mechanisms&lt;br /&gt;
&lt;br /&gt;
*Alters brain neurotransmitter content and release&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
*Respiratory: dyspnea, cyanosis, hemoptysis, rales, delayed pulmonary edema&lt;br /&gt;
&lt;br /&gt;
*Ophthalmic: conjunctivitis, corneal ulceration, corneal scarring&lt;br /&gt;
&lt;br /&gt;
*Central nervous system: headache, weakness, disequilibrium, intention tremor, muscle rigidity, loss of consciousness, seizures, coma&lt;br /&gt;
&lt;br /&gt;
*Gastrointestinal: green-gray line on gingiva, nausea, vomiting&lt;br /&gt;
&lt;br /&gt;
*Cardiovascular: chest pain, bradycardia&lt;br /&gt;
&lt;br /&gt;
*Neuropsychiatric: amnesia, lack of insight, disorientation, delirium, dementia&lt;br /&gt;
*Death&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Carbon Monoxide Toxicity&lt;br /&gt;
&lt;br /&gt;
Cyanide Toxicity&lt;br /&gt;
&lt;br /&gt;
Hydrocarbon Toxicity&lt;br /&gt;
&lt;br /&gt;
Smoke Inhalation Injury&lt;br /&gt;
&lt;br /&gt;
==Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
*No single test to verify exposure or levels&lt;br /&gt;
&lt;br /&gt;
*ABG: metabolic acidosis and normal oxygen saturation (unless pulmonary edema present)&lt;br /&gt;
&lt;br /&gt;
*Elevated lactate&lt;br /&gt;
&lt;br /&gt;
*Discolored copper coins found on patient may be helpful in diagnosis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
*Removal from source&lt;br /&gt;
&lt;br /&gt;
*100% oxygen&lt;br /&gt;
&lt;br /&gt;
*Can give nitrite component of cyanide antidote kit (do NOT give the thiosulfate portion): &lt;br /&gt;
**Theoretically increasing methemoglobin formation in blood will cause conversion of sulfide to sulfmethemoglonin (less toxic)&lt;br /&gt;
**Sodium nitrite (3% NaNO2) IV over 2-4 minutes&lt;br /&gt;
**Adult dose: 10 mL&lt;br /&gt;
**Obtain methemoglobin level 30 minutes after dose (desired level &amp;lt; 30%)&lt;br /&gt;
&lt;br /&gt;
*Hyperbaric oxygen therapy (though not proven to have any benefit)&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
*Admission, likely to MICU&lt;br /&gt;
&lt;br /&gt;
*Toxicology consult&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli’s Emergency Medicine&lt;br /&gt;
&lt;br /&gt;
Goldfrank’s Toxicologic Emergencies&lt;br /&gt;
&lt;br /&gt;
Medscape&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
#One of the few chemical asphyxiants that also possesses irritative properities&lt;br /&gt;
##Respiratory, ocular irritation&lt;br /&gt;
#High conc exposure may result in LOC, seizure, and death after only a few breaths&lt;br /&gt;
##Delayed pulm edema and corneal destruction should be anticipated w/ massive exposures&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
#Decontamination of skin/eyes&lt;br /&gt;
#O2 100% NRB&lt;br /&gt;
#Consider giving nitrite component of CN kit (do not give thiosulfate portion)&lt;br /&gt;
##Low level MetHb may enhance conversion of sulfide to less toxic sulfmethemoglobin&lt;br /&gt;
&lt;br /&gt;
==Source==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Tox]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22784</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22784"/>
		<updated>2014-08-11T02:51:17Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
Ceftriaxone 2mg IV q 24 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
Ciprofloxacin 400 mg IV q 12 hrs x 10 days; Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days; if nalidixic acid resistant, can assume fluoroquinolone resistant&lt;br /&gt;
&lt;br /&gt;
Azithromycin 1 g PO daily x 5 days&lt;br /&gt;
&lt;br /&gt;
Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
UpToDate&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22783</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22783"/>
		<updated>2014-08-11T02:50:59Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
Ceftriaxone 2mg IV q 24 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
Ciprofloxacin 400 mg IV q 12 hrs x 10 days; Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days; if nalidixic acid resistant, can assume fluoroquinolone resistant&lt;br /&gt;
&lt;br /&gt;
Azithromycin 1 g PO daily x 5 days&lt;br /&gt;
&lt;br /&gt;
Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
UpToDate&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
# tx empirically with flouroquinolone or 3rd gen cephal&lt;br /&gt;
# vaccine partially effecive and breakthrough infc possible&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22782</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22782"/>
		<updated>2014-08-11T02:50:46Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
Ceftriaxone 2mg IV q 24 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
Ciprofloxacin 400 mg IV q 12 hrs x 10 days; Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days; if nalidixic acid resistant, can assume fluoroquinolone resistant&lt;br /&gt;
&lt;br /&gt;
Azithromycin 1 g PO daily x 5 days&lt;br /&gt;
&lt;br /&gt;
Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
UpToDate&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Template:Fever in Traveler DDX}}&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
# tx empirically with flouroquinolone or 3rd gen cephal&lt;br /&gt;
# vaccine partially effecive and breakthrough infc possible&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22781</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22781"/>
		<updated>2014-08-11T02:50:16Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==DDX:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
Ceftriaxone 2mg IV q 24 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
Ciprofloxacin 400 mg IV q 12 hrs x 10 days; Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days; if nalidixic acid resistant, can assume fluoroquinolone resistant&lt;br /&gt;
&lt;br /&gt;
Azithromycin 1 g PO daily x 5 days&lt;br /&gt;
&lt;br /&gt;
Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
UpToDate&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Template:Fever in Traveler DDX}}&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
# tx empirically with flouroquinolone or 3rd gen cephal&lt;br /&gt;
# vaccine partially effecive and breakthrough infc possible&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22780</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22780"/>
		<updated>2014-08-11T02:49:58Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: typhoid fever update&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Typhoid Fever. Catherine Neal, MD and Alex Koyfman, MD. Department of Emergency Medicine, UT Southwestern Medical Center / Parkland Memorial Hospital, Dallas, Texas, USA&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Symptoms:==&lt;br /&gt;
&lt;br /&gt;
Classic symptoms:&lt;br /&gt;
&lt;br /&gt;
*Bradycardia relative to fever&lt;br /&gt;
&lt;br /&gt;
Initial symptoms: &lt;br /&gt;
&lt;br /&gt;
*Fever&lt;br /&gt;
&lt;br /&gt;
*Abdominal pain&lt;br /&gt;
&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
Subsequent symptoms:&lt;br /&gt;
&lt;br /&gt;
*Chills (rarely rigors)&lt;br /&gt;
&lt;br /&gt;
*Cough&lt;br /&gt;
&lt;br /&gt;
*Abdominal distension&lt;br /&gt;
&lt;br /&gt;
*Constipation (more common than diarrhea)&lt;br /&gt;
&lt;br /&gt;
*“Rose spots” – truncal light red macular rash (in the 2nd wk)&lt;br /&gt;
&lt;br /&gt;
*Prostration&lt;br /&gt;
&lt;br /&gt;
*Hepatosplenomegaly&lt;br /&gt;
&lt;br /&gt;
*GI bleeding&lt;br /&gt;
&lt;br /&gt;
*Transaminitis&lt;br /&gt;
&lt;br /&gt;
*Leukopenia with left shift (adults)&lt;br /&gt;
&lt;br /&gt;
*Leukocytosis (children)&lt;br /&gt;
&lt;br /&gt;
==Diagnosis and Work-Up:==&lt;br /&gt;
&lt;br /&gt;
Blood culture&lt;br /&gt;
&lt;br /&gt;
Urine culture&lt;br /&gt;
&lt;br /&gt;
Stool culture&lt;br /&gt;
&lt;br /&gt;
“Rose spot” aspiration&lt;br /&gt;
&lt;br /&gt;
Bone marrow culture (most sensitive)&lt;br /&gt;
&lt;br /&gt;
Sensitivity testing for nalidixic acid&lt;br /&gt;
&lt;br /&gt;
==Complications:==&lt;br /&gt;
&lt;br /&gt;
Small-bowel ulceration&lt;br /&gt;
&lt;br /&gt;
Intestinal perforation&lt;br /&gt;
&lt;br /&gt;
Anemia&lt;br /&gt;
&lt;br /&gt;
DIC&lt;br /&gt;
&lt;br /&gt;
Pneumonia&lt;br /&gt;
&lt;br /&gt;
Meningitis&lt;br /&gt;
&lt;br /&gt;
Myocarditis&lt;br /&gt;
&lt;br /&gt;
Cholecystitis&lt;br /&gt;
&lt;br /&gt;
Renal failure&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state&lt;br /&gt;
&lt;br /&gt;
==DDX:==&lt;br /&gt;
&lt;br /&gt;
Malaria&lt;br /&gt;
&lt;br /&gt;
Typhus&lt;br /&gt;
&lt;br /&gt;
Viral hepatitis&lt;br /&gt;
&lt;br /&gt;
Amebic Liver Abscess&lt;br /&gt;
&lt;br /&gt;
Infectious enteritis&lt;br /&gt;
&lt;br /&gt;
==Treatment:==&lt;br /&gt;
&lt;br /&gt;
Ceftriaxone 2mg IV q 24 hrs x 14 days&lt;br /&gt;
&lt;br /&gt;
Ciprofloxacin 400 mg IV q 12 hrs x 10 days; Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days; if nalidixic acid resistant, can assume fluoroquinolone resistant&lt;br /&gt;
&lt;br /&gt;
Azithromycin 1 g PO daily x 5 days&lt;br /&gt;
&lt;br /&gt;
Cefixime 10-15 mg/kg IV q 12 hrs x 8 days&lt;br /&gt;
&lt;br /&gt;
If associated delirium, coma, shock, and/or DIC: Dexamethasone 3 mg/kg IV load over 30 minutes, then 1 mg/kg IV every 6 hours x 8 doses&lt;br /&gt;
&lt;br /&gt;
==Disposition:==&lt;br /&gt;
&lt;br /&gt;
Admit if any complication&lt;br /&gt;
&lt;br /&gt;
==Sources:==&lt;br /&gt;
&lt;br /&gt;
Tintinalli&lt;br /&gt;
&lt;br /&gt;
UpToDate&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
# fvr, ha&lt;br /&gt;
# abd pain, constipation, -diarrhea rare&lt;br /&gt;
# leukopenia, thrombocytopenia, dry cough, LN&lt;br /&gt;
# insidious onset unlike dengue or rickettsia&lt;br /&gt;
# dx by blood cx for salmonella enterica serotype typhi&lt;br /&gt;
# serology unreliable&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Template:Fever in Traveler DDX}}&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
# tx empirically with flouroquinolone or 3rd gen cephal&lt;br /&gt;
# vaccine partially effecive and breakthrough infc possible&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22779</id>
		<title>Typhoid fever</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Typhoid_fever&amp;diff=22779"/>
		<updated>2014-08-11T02:42:21Z</updated>

		<summary type="html">&lt;p&gt;Cathylewwho: background updated&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
Diagnosed in 2% of febrile travelers&lt;br /&gt;
&lt;br /&gt;
Caused by ''Salmonella enterica serotype Typhi'' (formerly ''Salmonella typhi'') ''serotype paratyphi A, B, and C''&lt;br /&gt;
&lt;br /&gt;
Endemic in Mexico, Indonesia, Peru, and the Indian subcontinent&lt;br /&gt;
&lt;br /&gt;
Prior vaccination does not exclude infection&lt;br /&gt;
&lt;br /&gt;
Incubation period 1-3 weeks&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state defined as organism in urine or stool &amp;gt; 12 months&lt;br /&gt;
&lt;br /&gt;
Chronic carrier state risk factors: biliary tract abnormalities&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
# fvr, ha&lt;br /&gt;
# abd pain, constipation, -diarrhea rare&lt;br /&gt;
# leukopenia, thrombocytopenia, dry cough, LN&lt;br /&gt;
# insidious onset unlike dengue or rickettsia&lt;br /&gt;
# dx by blood cx for salmonella enterica serotype typhi&lt;br /&gt;
# serology unreliable&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
{{Template:Fever in Traveler DDX}}&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
# tx empirically with flouroquinolone or 3rd gen cephal&lt;br /&gt;
# vaccine partially effecive and breakthrough infc possible&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
[[Travel Medicine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:ID]]&lt;br /&gt;
[[Category:TropMed]]&lt;/div&gt;</summary>
		<author><name>Cathylewwho</name></author>
	</entry>
</feed>